Sep 08, 2025
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Jan 16, 2025
Servier and Google Cloud Expand Partnership on using Data and AI
Oct 08, 2020
Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure
Jul 23, 2020
Coalition Innovation Santé: Chronolife, with the support of Servier, Launches in France a Non-Invasive Telemonitoring Solution for the Continuous Monitoring of Patients Suffering from Chronic Diseases
Jun 04, 2020
Servier Completes the Acquisition of Symphogen
Feb 26, 2020
Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis
Jul 16, 2019
Pall Corporation Chosen as Single-Source Supplier by Servier for Purpose Built End-to-End Biomanufacturing Facility in Gidy, France
Jun 03, 2019
Taiho Oncology and Servier Present LONSURF® (trifluridine and tipiracil) Data at the 2019 ASCO Annual Meeting
Apr 04, 2019
Servier and Ipsen Join Access Accelerated to Fight Growing NCD Burden
Mar 20, 2019
Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis
Feb 21, 2019
Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure
Jan 17, 2019
Taiho Oncology and Servier Present Data on LONSURF® (trifluridine/tipiracil) at ASCO 2019 Gastrointestinal Cancers Symposium (ASCO GI)
Oct 21, 2018
Taiho Oncology and Servier Announce Positive Results from LONSURF® (trifluridine/tipiracil) Study Presented at ESMO 2018 Congress and Published in The Lancet Oncology
Jun 21, 2018
Taiho Oncology and Servier Present Data on LONSURF® (trifluridine and tipiracil) at ESMO 20th World Congress on Gastrointestinal Cancer 2018
Apr 13, 2018
Taiho Oncology Presents Data on LONSURF® (trifluridine and tipiracil) and Key Investigational Compounds at the 109th Annual Meeting of the American Association for Cancer Research
Feb 14, 2018
ImmunoQure AG and Servier Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody
Jan 20, 2018
Taiho Oncology and Servier Present LONSURF® (trifluridine and tipiracil) Metastatic Colorectal Cancer (mCRC) Data at ASCO 2018 Gastrointestinal Cancers Symposium
Jan 04, 2018
Servier and Treventis begin strategic research partnership in neurodegenerative diseases
Oct 19, 2017
Servier CDMO expands Preparative Chromatography platform at Normandy Site to support market need